Ignite Creation Date:
2025-12-24 @ 3:56 PM
Ignite Modification Date:
2026-01-01 @ 12:12 PM
Study NCT ID:
NCT07218692
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-10-20
First Post:
2025-10-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy
Sponsor:
City of Hope Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-08-11
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-08-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-08-11
Completion Date Type:
ESTIMATED
First Submit Date:
2025-10-16
First Submit QC Date:
None
Study First Post Date:
2025-10-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-16
Last Update Post Date:
2025-10-20
Last Update Post Date Type:
ESTIMATED